Development and validation of a contrast-enhanced CT-based radiomics nomogram for preoperative diagnosis in neuroendocrine carcinoma of digestive system

被引:0
|
作者
Xu, Liang [1 ]
Yang, Xinyi [1 ]
Xiang, Wenxuan [2 ]
Hu, Pengbo [1 ]
Zhang, Xiuyuan [1 ]
Li, Zhou [1 ]
Li, Yiming [1 ]
Liu, Yongqing [1 ]
Dai, Yuhong [1 ]
Luo, Yan [3 ]
Qiu, Hong [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
radiomics; contrast-enhanced CT; neuroendocrine carcinoma; diagnosis model; digestive system; HETEROGENEITY;
D O I
10.3389/fendo.2023.1155307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo develop and validate a contrast-enhanced CT-based radiomics nomogram for the diagnosis of neuroendocrine carcinoma of the digestive system. MethodsThe clinical data and contrast-enhanced CT images of 60 patients with pathologically confirmed neuroendocrine carcinoma of the digestive system and 60 patients with non-neuroendocrine carcinoma of the digestive system were retrospectively collected from August 2015 to December 2021 at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, and randomly divided into a training cohort (n=84) and a validation cohort (n=36). Clinical characteristics were analyzed by logistic regression and a clinical diagnosis model was developed. Radiomics signature were established by extracting radiomic features from contrast-enhanced CT images. Based on the radiomic signature and clinical characteristics, radiomic nomogram was developed. ROC curves and Delong's test were used to evaluate the diagnostic efficacy of the three models, calibration curves and application decision curves were used to analyze the accuracy and clinical application value of nomogram. ResultsLogistic regression results showed that TNM stage (stage IV) (OR 6.8, 95% CI 1.320-43.164, p=0. 028) was an independent factor affecting the diagnosis for NECs of the digestive system, and a clinical model was constructed based on TNM stage (stage IV). The AUCs of the clinical model, radiomics signature, and radiomics nomogram for the diagnosis of NECs of the digestive system in the training, validation cohorts and pooled patients were 0.643, 0.893, 0.913; 0.722, 0.867, 0.932 and 0.667, 0.887, 0.917 respectively. The AUCs of radiomics signature and radiomics nomogram were higher than clinical model, with statistically significant difference (Z=4.46, 6.85, both p < 0.001); the AUC difference between radiomics signature and radiomics nomogram was not statistically significant (Z=1.63, p = 0.104). The results of the calibration curve showed favorable agreement between the predicted values of the nomogram and the pathological results, and the decision curve analysis indicated that the nomogram had favorable application in clinical practice. ConclusionsThe nomogram constructed based on contrast-enhanced CT radiomics and clinical characteristics was able to effectively diagnose neuroendocrine carcinoma of the digestive system.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Contrast-enhanced CT-based radiomics model for differentiating risk subgroups of thymic epithelial tumors
    Yu, Chunhai
    Li, Ting
    Yang, Xiaotang
    Zhang, Ruiping
    Xin, Lei
    Zhao, Zhikai
    Cui, Jingjing
    BMC MEDICAL IMAGING, 2022, 22 (01)
  • [32] Contrast-enhanced CT-based radiomics model for differentiating risk subgroups of thymic epithelial tumors
    Chunhai Yu
    Ting Li
    Xiaotang Yang
    Ruiping Zhang
    Lei Xin
    Zhikai Zhao
    Jingjing Cui
    BMC Medical Imaging, 22
  • [33] Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study
    Jayoung Moon
    Jeong Hoon Lee
    Jin Roh
    Da Hyun Lee
    Eun Ju Ha
    Scientific Reports, 13 (1)
  • [34] Radiomics model based on contrast-enhanced CT texture features for pretreatment prediction of overall survival in esophageal neuroendocrine carcinoma
    Zhou, Yue
    Song, Lijie
    Xia, Jin
    Liu, Huan
    Xing, Jingjing
    Gao, Jianbo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] Development and validation of a combined nomogram model based on deep learning contrast-enhanced ultrasound and clinical factors to predict preoperative aggressiveness in pancreatic neuroendocrine neoplasms
    Jingzhi Huang
    Xiaohua Xie
    Hong Wu
    Xiaoer Zhang
    Yanling Zheng
    Xiaoyan Xie
    Yi Wang
    Ming Xu
    European Radiology, 2022, 32 : 7965 - 7975
  • [36] Development and validation of a combined nomogram model based on deep learning contrast-enhanced ultrasound and clinical factors to predict preoperative aggressiveness in pancreatic neuroendocrine neoplasms
    Huang, Jingzhi
    Xie, Xiaohua
    Wu, Hong
    Zhang, Xiaoer
    Zheng, Yanling
    Xie, Xiaoyan
    Wang, Yi
    Xu, Ming
    EUROPEAN RADIOLOGY, 2022, 32 (11) : 7965 - 7975
  • [37] Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study
    Moon, Jayoung
    Lee, Jeong Hoon
    Roh, Jin
    Lee, Da Hyun
    Ha, Eun Ju
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [38] Development and validation of a CT based radiomics nomogram for preoperative prediction of ISUP/WHO grading in renal clear cell carcinoma
    Liu, Xiaohui
    Han, Xiaowei
    Wang, Xu
    Xu, Kaiyuan
    Wang, Mingliang
    Zhang, Guozheng
    ABDOMINAL RADIOLOGY, 2025, 50 (03) : 1228 - 1239
  • [39] Dual-phase contrast-enhanced CT-based intratumoral and peritumoral radiomics for preoperative prediction of lymph node metastasis in gastric cancer
    Zhou, Yun-hui
    Chen, Xiao-li
    Zhang, Xin
    Pu, Hong
    Li, Hang
    BMC GASTROENTEROLOGY, 2025, 25 (01)
  • [40] A Contrast-Enhanced CT-Based Deep Learning System for Preoperative Prediction of Colorectal Cancer Staging and RAS Mutation
    Lu, Na
    Guan, Xiao
    Zhu, Jianguo
    Li, Yuan
    Zhang, Jianping
    CANCERS, 2023, 15 (18)